BENHomo sapiens (Human)Cancer cell line

Also known as: 1BEN

🤖 AI SummaryBased on 9 publications

Quick Overview

Human lung cancer cell line with known genetic alterations.

Detailed Summary

The BEN cell line is a human lung cancer cell line derived from a poorly differentiated squamous cell carcinoma of the bronchus. It has been extensively studied for its genetic and molecular characteristics, including the presence of immunoreactive calcitonin and carcinoembryonic antigen-like material. The cell line has been used in research to understand the biological and clinical implications of cancer-related mutations and their impact on tumor behavior. BEN is also noted for its utility in studying the effects of various therapeutic agents and in the development of targeted cancer therapies. The cell line has been part of several large-scale genomic and transcriptomic studies, contributing to the understanding of cancer genomics and the identification of potential biomarkers for cancer diagnosis and treatment.

Research Applications

Genomic and transcriptomic analysisDrug sensitivity profilingImmunological studiesCancer biology research

Key Characteristics

Immunoreactive calcitonin productionCarcinoembryonic antigen-like material expressionGenetic alterations associated with cancer progression
Generated on 6/16/2025

Basic Information

Database IDCVCL_1082
SpeciesHomo sapiens (Human)
Tissue SourceSupraclavicular lymph node[UBERON:UBERON_0035279]

Donor Information

Age71
Age CategoryAdult
SexMale

Disease Information

DiseaseLung non-small cell carcinoma
LineageLung
SubtypeNon-Small Cell Lung Cancer
OncoTree CodeNSCLC

DepMap Information

Source TypeDSMZ
Source IDACH-000603_source

Known Sequence Variations

TypeGene/ProteinDescriptionZygosityNoteSource
MutationSimpleTP53p.Tyr163Cys (c.488A>G)Unspecified-PubMed=12884349

Haplotype Information (STR Profile)

Short Tandem Repeat (STR) profile for cell line authentication.

Amelogenin
X
CSF1PO
10
D13S317
12
D16S539
11
D18S51
15,16,18
D19S433
14,15
D21S11
30
D2S1338
17,23
D3S1358
14
D5S818
12
D7S820
12
D8S1179
8
FGA
21,25
Penta D
12
Penta E
20
TH01
6
TPOX
8,9
vWA
15
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines

Loading gene expression data...

Publications

Pan-cancer proteomic map of 949 human cell lines.";

Robinson P.J., Zhong Q., Garnett M.J., Reddel R.R.

Cancer Cell 40:835-849.e8(2022).

Next-generation characterization of the Cancer Cell Line Encyclopedia.

Sellers W.R.

Nature 569:503-508(2019).

An interactive resource to probe genetic diversity and estimated ancestry in cancer cell lines.

Dutil J., Chen Z.-H., Monteiro A.N.A., Teer J.K., Eschrich S.A.

Cancer Res. 79:1263-1273(2019).

A landscape of pharmacogenomic interactions in cancer.";

Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.

Cell 166:740-754(2016).

TCLP: an online cancer cell line catalogue integrating HLA type, predicted neo-epitopes, virus and gene expression.

Loewer M., Sahin U., Castle J.C.

Genome Med. 7:118.1-118.7(2015).

A resource for cell line authentication, annotation and quality control.

Neve R.M.

Nature 520:307-311(2015).

A comprehensive transcriptional portrait of human cancer cell lines.

Settleman J., Seshagiri S., Zhang Z.-M.

Nat. Biotechnol. 33:306-312(2015).

The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.

Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.

Nature 483:603-607(2012).

A genome-wide screen for microdeletions reveals disruption of polarity complex genes in diverse human cancers.

Haber D.A.

Cancer Res. 70:2158-2164(2010).

Signatures of mutation and selection in the cancer genome.";

Deloukas P., Yang F.-T., Campbell P.J., Futreal P.A., Stratton M.R.

Nature 463:893-898(2010).

Analysis of chromosomal alterations in non-small cell lung cancer by multiplex-FISH, comparative genomic hybridization, and multicolor bar coding.

Petersen I.

Lab. Invest. 80:1031-1041(2000).

Monoclonal antibodies against two human lung carcinoma cell lines.";

Brown D.T., Moore M.

Br. J. Cancer 46:794-801(1982).

Immunoreactive calcitonin production by human lung carcinoma cells in culture.

Gilby E.D., Greenberg P.B., Neville A.M.

Br. J. Cancer 32:373-379(1975).